A simulated analysis in psoriasis highlights divergent patient and payer incentives and inconsistent coverage strategies behind barriers to phototherapy uptake.

On Aug. 29, Medicare released its highly anticipated list of 10 therapies for which it plans to establish a price by 2026. The Inflation Reduction Act (IRA), passed in August 2022, gives Medicare ...

Biocon Biologics is among the leading global suppliers of biosimilar insulins and has been expanding its portfolio ...

The Nobel Prize in Medicine will never be awarded for excellence in the formulation and manufacture of biologic medicines. That’s understandable. Patients who need these medicines deserve the product ...

Adma Biologics (ADMA) ended the recent trading session at $14.99, demonstrating a -4.34% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily loss of ...

Altruist Biologics, an Innovent Biologics subsidiary and world-class contract development and manufacturing organization (CDMO), recently announced the launch of Altru-CON, a high-concentration ...

IDBS, a leading provider of cloud software for biopharma companies and a Danaher company, is proud to announce that it has been awarded the Best Biologics Digitalisation: Software Innovation Award, at ...

Just how like finding the perfect shade of foundation or the holy grail of running shoes can take a bit of trial and error, so can finding the right treatment for an autoimmune disease like psoriasis.

WuXi Biologics ('WuXi Bio') (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has won six prestigious awards and two individual ...

Asthma biologic use was not associated with an increase in respiratory infection risk, according to results from the 2026 ...